JFNIX
Price
$70.64
Change
+$0.56 (+0.80%)
Updated
Sep 5 closing price
Net Assets
4.28B
LHCSX
Price
$19.73
Change
+$0.11 (+0.56%)
Updated
Sep 4 closing price
Net Assets
7.8M
Interact to see
Advertisement

JFNIX vs LHCSX

Header iconJFNIX vs LHCSX Comparison
Open Charts JFNIX vs LHCSXBanner chart's image
Janus Henderson Global Life Sciences I
Price$70.64
Change+$0.56 (+0.80%)
VolumeN/A
Net Assets4.28B
Lord Abbett Health Care R4
Price$19.73
Change+$0.11 (+0.56%)
VolumeN/A
Net Assets7.8M
JFNIX vs LHCSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JFNIX vs. LHCSX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNIX is a Buy and LHCSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.29B vs. LHCSX (7.8M). JFNIX pays higher dividends than LHCSX: JFNIX (0.39) vs LHCSX (0.32). JFNIX was incepted earlier than LHCSX: JFNIX (16 years) vs LHCSX (6 years). LHCSX (3.34) is less costly to investors than JFNIX (0.77). LHCSX is a more actively managed with annual turnover of: 88.00 vs. JFNIX (35.00). LHCSX has a lower initial minimum investment than JFNIX: LHCSX (0) vs JFNIX (2500). LHCSX annual gain was more profitable for investors over the last year : -1.74 vs. JFNIX (-12.88). JFNIX return over 5 years is better than : 10.19 vs. LHCSX (8.98).
JFNIXLHCSXJFNIX / LHCSX
Total Expense Ratio0.771.0375%
Annual Report Gross Expense Ratio0.773.3423%
Fund Existence16 years6 years-
Gain YTD3.8523.029127%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.29B7.8M54,964%
Annual Yield % from dividends0.390.32123%
Returns for 1 year-12.88-1.74741%
Returns for 3 years17.0218.3693%
Returns for 5 years10.198.98114%
Returns for 10 years22.06N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PUGCX15.930.07
+0.44%
Putnam Focused International Equity C
NBRCX27.050.10
+0.37%
Neuberger Berman M/C Intrinsic Val C
FFNTX13.950.04
+0.29%
Fidelity Advisor Asset Manager 40% M
MCEIX14.58N/A
N/A
Martin Currie Emerging Markets I
ICSFX31.36N/A
N/A
Invesco Comstock R6